Browse Category

Investment Analysis News 17 December 2025

Opendoor (OPEN) Stock News Today: Leadership Shake-Up, Warrant Dividend Fallout, and 2026 Forecasts (Dec. 17, 2025)

Opendoor (OPEN) Stock News Today: Leadership Shake-Up, Warrant Dividend Fallout, and 2026 Forecasts (Dec. 17, 2025)

Opendoor Technologies Inc. (NASDAQ: OPEN) is once again doing that very-2025 thing where a real estate company trades like a videogame boss fight: high volume, sharp swings, and nonstop debate over whether this is a turnaround story or a gravity
NVIDIA Stock Today: NVDA Holds Near $178 as AI Bubble Debate, Open-Source Push, and China Chip Policy Shape the Outlook

NVIDIA Stock Today: NVDA Holds Near $178 as AI Bubble Debate, Open-Source Push, and China Chip Policy Shape the Outlook

December 17, 2025 — NVIDIA Corporation (NASDAQ: NVDA) is trading around the $177–$178 area heading into Wednesday’s session, after closing Tuesday, Dec. 16 at $177.72. StockAnalysis That price level—steady, but not euphoric—captures the mood around Nvidia right now: investors are
Haleon PLC (HLN) News Today, 17 December 2025: Shares Rise as Investors Digest Morgan Stanley “Top Pick” Call and Incoming Board Changes

Haleon PLC (HLN) News Today, 17 December 2025: Shares Rise as Investors Digest Morgan Stanley “Top Pick” Call and Incoming Board Changes

Haleon PLC (LSE/NYSE: HLN) closed higher on 17 December 2025, rebounding after Tuesday’s dip. Here’s what’s moving the consumer-health giant behind Sensodyne, Panadol and Advil, including a Morgan Stanley upgrade, leadership changes effective 1 January 2026, and the next key
Lennar Stock (NYSE: LEN) Slides After Q4 2025 Earnings Miss: 2026 Guidance, Analyst Targets, and What Investors Are Watching

Lennar Stock (NYSE: LEN) Slides After Q4 2025 Earnings Miss: 2026 Guidance, Analyst Targets, and What Investors Are Watching

Updated: December 17, 2025 Lennar Corporation’s stock (NYSE: LEN) is in the spotlight on December 17, 2025 after the homebuilder reported fourth-quarter and full-year fiscal 2025 results late Tuesday and laid out a cautious early outlook for fiscal 2026. The
HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025)

HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025)

December 17, 2025 — HeartBeam, Inc. (NASDAQ: BEAT) has moved from “interesting microcap medtech story” to “market’s attention magnet” in a hurry. The spark: FDA 510(k) clearance for HeartBeam’s 12-lead ECG synthesis software for at-home arrhythmia assessment, granted after the
Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

December 17, 2025 — Rezolve AI PLC stock (NASDAQ: RZLV) is in the spotlight after a company update indicated a sharp step-up in expected year-end momentum: December revenue is projected to exceed $17 million, while the company now expects to
Coupang (CPNG) Stock News Today: Parliamentary Fallout, SEC Cyber Filing, and Fresh Wall Street Forecasts (Dec. 17, 2025)

Coupang (CPNG) Stock News Today: Parliamentary Fallout, SEC Cyber Filing, and Fresh Wall Street Forecasts (Dec. 17, 2025)

Coupang, Inc. (NYSE: CPNG) is under an intense spotlight on December 17, 2025, as investors digest a fast-moving mix of political pressure in South Korea, a material cybersecurity disclosure to U.S. regulators, and a rapidly shifting set of price targets
1 8 9 10 11 12 145
Go toTop